skip to main content

    Updated Visitor Guidelines

 

MENU

 

Rogel Cancer Center at the American Society of Hematology Annual Meeting

The 2019 ASH Annual Meeting and Exposition will feature more than 30 presentations by University of Michigan faculty and trainees.

Study Helps Identify Who May Benefit From Immunotherapy

While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. U-M Rogel Cancer Center researchers studied mice with colon cancer, ovarian cancer, melanoma and lung cancer to understand how expression of the protein PD-L1 affects response to its blockade. This is a key target of immunotherapy drugs.

Mercy Health, Metro Health University of Michigan Health, Michigan Medicine form Cancer Network of West Michigan

The Cancer Network of West Michigan is an initiative to integrate cancer care services in West Michigan formed by Mercy Health, Metrol Health, the University of Michigan Health and Michigan Medicine providing patients in western Michigan access to advanced, state-of-the-art, comprehensive diagnosis, treatment and support.

Yearly Mammograms Linked to Less Advanced Breast Cancer

A new study makes a case for getting screened every year instead of every other year. Women diagnosed with breast cancer after receiving yearly mammograms had smaller tumors and less-advanced disease than women who had mammograms every other year.

Researchers Achieve Elimination of Leukemia and Lymphoma Tumors in Mouse Models

STAT3 has been a major therapeutic target in the treatment of cancer. But it's largely been considered “undruggable” due to the difficulty of developing compounds to effectively inhibit its activity. Researchers at the U-M Rogel Cancer Center have a new approach to targeting STAT3.

Michigan Medicine Pioneers Bone Regeneration Device

Within minutes of breaking a bone, the body begins to repair itself, But when that process is impaired by age, diabetes or radiation treatment for cancer, surgeons at Michigan Medicine are pioneering a device shown to accelerate bone regeneration.

Six Rogel Cancer Center Members Names 2019 AAAS Fellows

The six U-M Rogel Cancer Center members are: Dr. Maria G. Castro, Dr. Jun Li, Dr. Linda C. Samuelson, Dr. Emily E. Scott, Dr. Shaomeng Wang, Dr. Weiping Zou.

Implantable cancer traps could provide earlier diagnosis and help monitor treatment

Invasive procedures to biopsy tissue from cancer-tainted organs could be replaced by simply taking samples from a tiny “decoy” implanted just beneath the skin, University of Michigan researchers have demonstrated in mice.

Rogel Cancer Center Researchers Discover Gene that Drives Prostate Cancer

A new study from researchers at the University of Michigan Rogel Cancer Center finds that the gene FOXA1 overrides normal biology in three different ways to drive prostate cancer. They refer to the three classes as FAST, FURIOUS, and LOUD to reflect their unique features. The findings are published in Nature.

Gabapentinoids Use with Cancer Patients Increasing

Between 2005 and 2015, prescriptions for gabapentinoid medications -- gabapentin and pregabalin -- to adults with cancer saw a two-fold increase, a U-M Rogel Cancer Center study has found.

Pages